Keeping Current

Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF). Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996906?ecd=bdc_podcast_libsyn_mscpedu

Expert tips to better select treatments, implement, and talk with patients. Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996660?ecd=bdc_podcast_libsyn_mscpedu

Do you know about the extra cardiac effects and other effects of angiotensin receptor-neprilysin inhibitors (ARNIs)? Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996323?ecd=bdc_podcast_libsyn_mscpedu

Do you know what the challenges are for patients and clinicians when managing C3 glomerulopathy, and what the role of emerging therapies is?

Credit available for this activity expires: 9/28/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996820?ecd=bdc_podcast_libsyn_mscpedu

How up to date is your knowledge of ongoing clinical trials in breast cancer? Ready to absorb new data releases at upcoming Autumn meetings?

Credit available for this activity expires: 9/27/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996833?ecd=bdc_podcast_libsyn_mscpedu

Are you choosing the right immunotherapy-based combination for the right patient? Watch this program to get clinical updates and expert insights. Credit available for this activity expires: 9/27/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996823?ecd=bdc_podcast_libsyn_mscpedu

Did you know that a biologic drug can undergo hundreds of authorized changes in its lifetime?

Credit available for this activity expires: 9/27/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996834?ecd=bdc_podcast_libsyn_mscpedu

Did you know therapeutic inertia is a key driver of uncontrolled type 2 diabetes? Credit available for this activity expires: 9/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996617?ecd=bdc_podcast_libsyn_mscpedu

Did you know that antivirals can lower the risk of COVID-19 hospitalization or death in high-risk individuals?

Credit available for this activity expires: 9/20/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996557?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on the latest lipid-lowering therapies? Drs Zambon and Taub discuss.

Credit available for this activity expires: 9/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996295?ecd=bdc_podcast_libsyn_mscpedu